Skip to main content
logo
Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
1.150
+0.010 (0.88%)
At close: Apr 24, 2026, 4:00 PM EDT
1.140
-0.010 (-0.87%)
After-hours: Apr 24, 2026, 7:47 PM EDT

Inovio Pharmaceuticals Revenue

In the year 2025, Inovio Pharmaceuticals had annual revenue of $65.34K, down -69.99%.

Revenue (ttm)
$65.34K
Revenue Growth
-69.99%
P/S Ratio
1,442.06
Revenue / Employee
$583
Employees
112
Market Cap
94.23M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202565.34K-152.41K-69.99%
Dec 31, 2024217.76K-614.25K-73.83%
Dec 31, 2023832.01K-9.43M-91.89%
Dec 31, 202210.26M8.49M478.24%
Dec 31, 20211.77M-5.64M-76.05%
Dec 31, 20207.41M--
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007---
Dec 31, 2006---
Dec 31, 2005---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Q32 Bio53.74M
Coya Therapeutics7.95M
NeurAxis3.57M
Rani Therapeutics Holdings1.63M
Coeptis Therapeutics Holdings1.36M
NRx Pharmaceuticals1.23M
Fractyl Health3.00K
eXoZymes-700.00
Revenue Rankings

INO News

More News